Christine Brideau - Concepedia

Author

Christine Brideau

Merck Canada Inc. (Canada)

Also Known As

Brideau, C., C Brideau, C. BRIDEAU, C. Brideau, Christine Brideau

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Merck Canada Inc. (Canada)Merck & Co., Inc., Rahway, NJ, USA (United States)TransCanada (Canada)Merck (United Kingdom)

About

Christine Brideau is an author at Merck Canada Inc. (Canada) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	39	2.8K
2	Natural Sciences	22	26	2.1K
3	Allergy	2	2	138
4	Engineering	1	1	28
5	Health Sciences	1	1	45

Christine Brideau

Publications

Citations

H-Index

Page 1

	Year	Citations
Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2 Denis Riendeau, M. David Percival, Christine Brideau, Journal of Pharmacology and Experimental Therapeutics	2001	456
The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor Petpiboon Prasit, Z Wang, Christine Brideau, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryActive Cyclooxygenase-2 InhibitorPharmaceutical ScienceBiochemistry	1999	426
Rofecoxib [Vioxx, MK-0966; 4-(4′-Methylsulfonylphenyl)-3-phenyl-2-(5 H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles Chi‐Chung Chan, S. Boyce, Christine Brideau, Journal of Pharmacology and Experimental Therapeutics	1999	397
Improved Statistical Methods for Hit Selection in High-Throughput Screening Christine Brideau, Bert Gunter, Bill Pikounis, SLAS DISCOVERY	2003	334
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor Denis Riendeau, M. David Percival, S. Boyce, British Journal of Pharmacology Pge2 ProductionChemoprevention StrategyImmunologyPharmacotherapyPharmaceutical Chemistry	1997	326
Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. Chi‐Chung Chan, S. Boyce, Christine Brideau, Journal of Pharmacology and Experimental Therapeutics	1995	313
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors Christine Brideau, Stacia Kargman, S. Liu, Inflammation Research Therapeutic Drug MonitoringMedicinal ChemistryPharmacological StudyBiochemistryNatural Sciences	1996	281
Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530 Daniel Dubé, Marc Blouin, Christine Brideau, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAldehyde DehydrogenaseBiochemistryPotent 5-Lipoxygenase InhibitorsNatural Sciences	1998	271
In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats Christine Brideau, Carlo van Staden, Chi Chung Chan American Journal of Veterinary Research	2001	209
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors Bernard Côté, Louise Boulet, Christine Brideau, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	2007	128

Page 1